(Q34449994)

2 August 2017

Identification of key pathways and transcription factors related to Parkinson disease in genome wide (English)

1 reference

2 August 2017

1 reference

Bin Zhang

1

1 reference

2 August 2017

Cuiping Xia

series ordinal

2

1 reference

2 August 2017

Qunfeng Lin

series ordinal

3

1 reference

2 August 2017

Jie Huang

series ordinal

4

1 reference

2 August 2017

18 October 2012

1 reference

Molecular Biology Reports

2 August 2017

1 reference

2 August 2017

39

1 reference

2 August 2017

12

1 reference

2 August 2017

10881-10887

1 reference

https://scigraph.springernature.com/pub.10.1007/s11033-012-1985-1

2 August 2017

0 references

cites work

Pathogenesis of nigral cell death in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Parkinson's disease: clinical features and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

A review of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Parkinson's disease: from monogenic forms to genetic susceptibility factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Gene therapy in Parkinson's disease: rationale and current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Missing pieces in the Parkinson's disease puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

A genomic pathway approach to a complex disease: axon guidance and Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

affy--analysis of Affymetrix GeneChip data at the probe level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

DiRE: identifying distant regulatory elements of co-expressed genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Pathway signature and cellular differentiation in clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Feedback regulation of EGFR signalling: decision making by early and delayed loops.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

21 January 2018

Targeting erbB receptors

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson's disease and its model: neurotrophic implication in nigrostriatal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Mutations in the LRRK2 Roc-COR tandem domain link Parkinson's disease to Wnt signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Caspase-3-derived C-terminal product of synphilin-1 displays antiapoptotic function via modulation of the p53-dependent cell death pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

The Parkinson disease protein α-synuclein inhibits autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Androgens induce dopaminergic neurotoxicity via caspase-3-dependent activation of protein kinase Cdelta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

A cross-study transcriptional analysis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Low cancer rates among patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Effects of intranigral vs intrastriatal fetal mesencephalic neural grafts on motor behavior disorders in a rat Parkinson model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: implications for progression of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Parkinson's disease tremor-related metabolic network: characterization, progression, and treatment effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

OCT4B1, a novel spliced variant of OCT4, generates a stable truncated protein with a potential role in stress response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Downregulation of transcription factor Oct4 induces an epithelial-to-mesenchymal transition via enhancement of Ca2+ influx in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Differential expression of Oct4 in HPV-positive and HPV-negative cervical cancer cells is not regulated by DNA methyltransferase 3A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Oct4-induced reprogramming is required for adult brain neural stem cell differentiation into midbrain dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

OCT1 polymorphism is associated with response and survival time in anti-Parkinsonian drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

FoxM1: a master regulator of tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Axial, a zebrafish gene expressed along the developing body axis, shows altered expression in cyclops mutant embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Sonic hedgehog-mediated ventralization disrupts formation of the midbrain-hindbrain junction in the chick embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

The winged helix transcription factor Hfh2 is expressed in neural crest and spinal cord during mouse development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

alpha-Synuclein locus triplication causes Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Association between early-onset Parkinson's disease and mutations in the parkin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

PINK1 protein in normal human brain and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1985-1

Immunology, autoimmunity, and autoantibodies in Parkinson's disease

21 January 2018

1 reference

12 December 2020

A Comparative Study of Mouse Hepatic and Intestinal Gene Expression Profiles under PPARα Knockout by Gene Set Enrichment Analysis

1 reference

12 December 2020

Studies on the carcinogenicity of potassium iodide in F344 rats

1 reference

12 December 2020

Autoimmune disease in a DFNA6/14/38 family carrying a novel missense mutation in WFS1.

1 reference

12 December 2020

Immunoprotection against toxic biomarkers is retained during Parkinson's disease progression

1 reference

12 December 2020

10.1007/S11033-012-1985-1

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference